Many compounds exhibit NR2B-specific modulation of the N-methyl-D-aspartate receptor, although their mechanism(s) of action are largely unknown. Using chimeric NR2A/NR2B subunits, we have located a region of NR2B (amino acids 138 -238) which regulated glycineindependent polyamine stimulation. Mutation of glutamate 201 in this region affected stimulation by polyamines in the order E201D < E201A < E201N < E201R. The relief of proton inhibition of the N-methyl-D-aspartate-induced currents mediated by these mutant receptors correlated with the reduction in glycine-independent polyamine stimulation. Electrophysiological evidence with a triple mutant of NR2A further supports the hypothesis that polyamine stimulation may be linked to the relief of tonic inhibition by protons and demonstrates the crucial role of amino acids 200 and 201 in polyamine stimulation. Polyamines and protons, therefore, share common NR2B determinants.1 receptor is a multimeric ligand-gated ion channel that plays a key role in glutamatergic transmission in the central nervous system (1-4). The activated NMDA receptor increases the neuronal membrane permeability to Ca 2ϩ and has been implicated in epilepsy (5), Huntington's disease (6), and the delayed neuronal death following cerebral ischemia (7). NMDA receptor activation requires both glutamate and glycine and is modulated by many channel-blocking agents and noncompetitive inhibitors (8). Dizocilpine (MK-801) (9) and phencyclidine block the channel in the open conformation (10) and have been vital for the pharmacologic characterization of these receptors, although the psychomimetic effects conferred by these agents prohibit their clinical use (4). Agents that modulate NMDA receptors at other sites, including the noncompetitive antagonist ifenprodil (11), the endogenous polyamine spermidine (12), and the -site ligand haloperidol (13), may provide better models for novel therapeutic design because they do not produce psychomimetic effects.The differential assembly of NMDA receptor subunits leads to receptors with distinct pharmacologies. The receptor is proposed to exist as multimeric channels composed of five subunits of two types (NR1 and NR2) (14). There are eight forms of NR1 (NR1A-H), derived by alternate splicing (1, 15), and four known NR2 subunits (NR2A-NR2D) (14,16,17). The cDNAs for murine NR1 subunits () and NR2 subunits (⑀ 1 -⑀ 4 ) (18 -20) share greater than 99% amino acid homology with their rat counterparts, explaining the observation that coexpression of rat NR1 with murine NR2 subunits yields receptors with properties identical to those of channels made from all rat subunits (21-23). Heterologous expression of NR1 and NR2 subunits in oocyte and cell culture systems has shown that NR1A/2A receptors differ pharmacologically from NR1A/2B receptors (16 -19, 24 -27). Modulators that exhibit NR2B-specific interactions include ifenprodil, polyamines, and haloperidol (22,27,28).Polyamines are endogenous compounds in the central nervous system, although their function in the brain is lar...